申请人:Genentech, Inc.
公开号:US08952169B2
公开(公告)日:2015-02-10
The invention provides novel compounds having the general formula:
and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, B, R1, R2, R3, R4, R5 and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
该发明提供了具有以下一般式的新化合物及其药学上可接受的盐:
其中变量RA,下标n,环A,X2,L,下标m,X1,B,R1,R2,R3,R4,R5和RN具有如下所述的含义,以及含有此类化合物的组合物和使用此类化合物和组合物的方法。